These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 33566325)

  • 1. Sarcopenia, immune-mediated rheumatic diseases, and nutritional interventions.
    Cruz-Jentoft AJ; Romero-Yuste S; Chamizo Carmona E; Nolla JM
    Aging Clin Exp Res; 2021 Nov; 33(11):2929-2939. PubMed ID: 33566325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Efficacy of Biological Disease-modifying Antirheumatic Drugs on Sarcopenia in Patients with Rheumatoid Arthritis.
    Hasegawa E; Ito S; Kurosawa Y; Kobayashi D; Otani H; Abe A; Nakazono K; Murasawa A; Narita I; Ishikawa H
    Intern Med; 2023; 62(3):373-379. PubMed ID: 36725065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of biologic and target synthetic disease-modifying anti-rheumatic drugs on sarcopenia in spondyloarthritis and rheumatoid arthritis: a systematic review and meta-analysis.
    Ben Tekaya A; Mehmli T; Ben Sassi M; Teyeb Z; Bouden S; Rouached L; Mahmoud I; Dziri C; Abdelmoula L
    Clin Rheumatol; 2023 Apr; 42(4):979-997. PubMed ID: 36462127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and factors associated with sarcopenia in patients with rheumatoid arthritis.
    Torii M; Hashimoto M; Hanai A; Fujii T; Furu M; Ito H; Uozumi R; Hamaguchi M; Terao C; Yamamoto W; Uda M; Nin K; Morita S; Arai H; Mimori T
    Mod Rheumatol; 2019 Jul; 29(4):589-595. PubMed ID: 30092163
    [No Abstract]   [Full Text] [Related]  

  • 5. Muscle Strength Comparison in Immune-Mediated Rheumatic Disease vs Healthy Adults: A Meta-Analysis.
    Cavalheiro do Espírito Santo R; Peterson Dos Santos L; Melo G; Prakash Dubey V; Rauckiene-Michaelsson A; Agostinis-Sobrinho C
    J Am Med Dir Assoc; 2024 Oct; 25(12):105293. PubMed ID: 39366668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound and magnetic resonance imaging as diagnostic tools for sarcopenia in immune-mediated rheumatic diseases (IMRDs).
    Salaffi F; Carotti M; Di Matteo A; Ceccarelli L; Farah S; Villota-Eraso C; Di Carlo M; Giovagnoni A
    Radiol Med; 2022 Nov; 127(11):1277-1291. PubMed ID: 36125609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporomandibular disorders in immune-mediated rheumatic diseases of the adult: A systematic review.
    Hysa E; Lercara A; Cere A; Gotelli E; Gerli V; Paolino S; Pizzorni C; Sulli A; Smith V; Cutolo M
    Semin Arthritis Rheum; 2023 Aug; 61():152215. PubMed ID: 37167773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of disease-modifying anti-rheumatic drugs on skeletal muscle mass in rheumatoid arthritis patients: a systematic review with meta-analysis.
    Hein TR; Peterson L; Bartikoski BJ; Portes J; Espírito Santo RC; Xavier RM
    Arthritis Res Ther; 2022 Jul; 24(1):171. PubMed ID: 35854372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Sarcopenia and its Association with Antirheumatic Drugs in Middle-Aged and Older Adults with Rheumatoid Arthritis: A Systematic Review and Meta-analysis.
    Dao T; Kirk B; Phu S; Vogrin S; Duque G
    Calcif Tissue Int; 2021 Nov; 109(5):475-489. PubMed ID: 34132852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcopenia in Autoimmune and Rheumatic Diseases: A Comprehensive Review.
    An HJ; Tizaoui K; Terrazzino S; Cargnin S; Lee KH; Nam SW; Kim JS; Yang JW; Lee JY; Smith L; Koyanagi A; Jacob L; Li H; Shin JI; Kronbichler A
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of biologic DMARDs on quality of life: 12-month results of a rheumatic diseases cohort using the Brazilian EQ-5D tariff.
    Alves de Oliveira Junior H; Pereira da Veiga T; Acurcio FA; Almeida AM; Ribeiro Dos Santos JB; da Silva MRR; Kakehasi AM; Cherchiglia ML
    Hosp Pract (1995); 2020 Oct; 48(4):213-222. PubMed ID: 32567403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcopenia-associated factors in Japanese patients with rheumatoid arthritis: A cross-sectional study.
    Mochizuki T; Yano K; Ikari K; Okazaki K
    Geriatr Gerontol Int; 2019 Sep; 19(9):907-912. PubMed ID: 31342647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparisons between comorbid conditions and health care consumption in rheumatoid arthritis patients with or without biological disease-modifying anti-rheumatic drugs: a register-based study.
    Bengtsson K; Jacobsson LT; Rydberg B; Kvist G; Torstenson T; Dehlin M; Hilme E; Lindhé A; Wallerstedt SM; Forsblad-d'Elia H
    BMC Musculoskelet Disord; 2016 Dec; 17(1):499. PubMed ID: 27955647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to biologic disease-modifying antirheumatic drugs in adult patients with rheumatic diseases.
    Fazaa A; Makhlouf Y; Ben Ouhiba A; Miladi S; Sellami M; Ouenniche K; Souabni L; Kassab S; Chekili S; Zakraoui L; Ben Abdelghani K; Laatar A
    Therapie; 2021; 76(5):467-474. PubMed ID: 32948325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcopenia in Immune-Mediated Rheumatic Diseases-Review.
    Santo RCDE; Baker JF; Santos LPD; Silva MMMD; Xavier RM
    J Clin Rheumatol; 2023 Oct; 29(7):354-362. PubMed ID: 36322934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation.
    Stevenson M; Archer R; Tosh J; Simpson E; Everson-Hock E; Stevens J; Hernandez-Alava M; Paisley S; Dickinson K; Scott D; Young A; Wailoo A
    Health Technol Assess; 2016 Apr; 20(35):1-610. PubMed ID: 27140438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammaging and Frailty in Immune-Mediated Rheumatic Diseases: How to Address and Score the Issue.
    Salaffi F; Di Matteo A; Farah S; Di Carlo M
    Clin Rev Allergy Immunol; 2023 Apr; 64(2):206-221. PubMed ID: 35596881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors.
    Barone M; Viggiani MT; Anelli MG; Fanizzi R; Lorusso O; Lopalco G; Cantarini L; Di Leo A; Lapadula G; Iannone F
    J Clin Med; 2018 Dec; 7(12):. PubMed ID: 30513782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibromyalgia interferes with disease activity and biological therapy response in inflammatory rheumatic diseases.
    Coskun Benlidayi I
    Rheumatol Int; 2020 Jun; 40(6):849-858. PubMed ID: 31900502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. POSSIBLE ROLE OF NUTRITION IN PREVENTION OF SARCOPENIA AND FALLS.
    Schneider DA; Trence DL
    Endocr Pract; 2019 Nov; 25(11):1184-1190. PubMed ID: 31412231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.